These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2831702)

  • 1. Dose-ranging study of isosorbide-5-mononitrate in chronic congestive heart failure treated with diuretics and angiotensin-converting enzyme inhibitor.
    Debbas N; Woodings D; Marks C; Bhans A; Jubber A; Dews I; Stephens J; Vandenburg M
    Am J Cardiol; 1988 Mar; 61(9):28E-30E. PubMed ID: 2831702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
    Schneeweiss A
    Am J Cardiol; 1988 Mar; 61(9):19E-21E. PubMed ID: 3126632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual isosorbide dinitrate in severe congestive heart failure.
    Markiewicz W; Rochman J; Peled B
    Cardiology; 1981; 67(3):172-9. PubMed ID: 7273045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
    Mehra A; Ostrzega E; Shotan A; Johnson JV; Elkayam U
    Am J Cardiol; 1992 Nov; 70(15):1310-4. PubMed ID: 1442583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of intravenous elantan and frusemide in patients with chronic cardiac failure.
    Hutton I; McGhie AI; Martin W; Tweddel AC
    Cardiology; 1987; 74 Suppl 1():65-8. PubMed ID: 3607806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.
    Remme WJ; van der Ent M; Bartels GL; van Schelven D; van Hoogenhuyze DC; Krauss XH; Kruijssen HA; Storm CJ
    Cardiovasc Drugs Ther; 1996 May; 10(2):137-44. PubMed ID: 8842505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
    Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
    Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
    Hall D; Zeitler H; Rudolph W
    J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
    Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
    Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to isosorbide dinitrate in patients with severe chronic heart failure: incidence and attempt at hemodynamic prediction.
    Kulick D; Roth A; McIntosh N; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1988 Oct; 12(4):1023-8. PubMed ID: 3417975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
    Cotter G; Metzkor E; Kaluski E; Faigenberg Z; Miller R; Simovitz A; Shaham O; Marghitay D; Koren M; Blatt A; Moshkovitz Y; Zaidenstein R; Golik A
    Lancet; 1998 Feb; 351(9100):389-93. PubMed ID: 9482291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.
    Gammage MD; Murray RG; Littler WA
    Eur J Clin Pharmacol; 1986; 29(6):639-43. PubMed ID: 3709607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
    Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
    Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse remodeling in heart failure with intensification of vasodilator therapy.
    Levine TB; Levine AB; Keteyian SJ; Narins B; Lesch M
    Clin Cardiol; 1997 Aug; 20(8):697-702. PubMed ID: 9259162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.